Pazopanib maintenance therapy after tandem high-dose chemotherapy for disseminated Ewing sarcoma

The dismal prognosis of patients with disseminated Ewing sarcoma necessitates the development of novel treatment strategies. Pazopanib is an oral multi-targeted tyrosine kinase inhibitor that is active against advanced soft tissue sarcoma. However, the clinical activity and feasibility of pazopanib...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Int Cancer Conf J
Autores principales: Tamura, Akihiro, Yamamoto, Nobuyuki, Nino, Nanako, Ichikawa, Takayuki, Nakatani, Naoko, Nakamura, Sayaka, Saito, Atsuro, Kozaki, Aiko, Kishimoto, Kenji, Ishida, Toshiaki, Yoshida, Makiko, Akasaka, Yoshinobu, Hasegawa, Daiichiro, Kosaka, Yoshiyuki
Formato: Artigo
Lenguaje:Inglês
Publicado: Springer Singapore 2019
Materias:
Case Report
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6545189/
https://ncbi.nlm.nih.gov/pubmed/31218182
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13691-019-00362-w
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares